<a href='https://email.asam.org/t/t-i-gdyuun-l-b/'>Evaluation of a Novel Patient-Centered Methadone Restart Protocol</a> 🔓
JAMA Network Open
Restarting methadone for patients who have had a gap in treatment is often a frustratingly slow process for both the patient and provider. This cohort study of individuals examined outcomes for patients of a public, safety-net opioid treatment program before (n=786 patients) and after (n=780 patients) implementation of a 2022 clinical protocol focused on individualized methadone restart doses based on opioid tolerance. Preimplementation restart doses were 32.8% lower than the last prior methadone dose, whereas postimplementation restart doses were only 3.4% lower than the last prior methadone dose. There was no significant change in patient safety (emergency department visits within 7 days after restart and all-cause mortality within 7 and 90 days after restart) or 90-day retention in care.
 
<a href='https://email.asam.org/t/t-e-gdyuun-l-ti/'>Read this issue of the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/409ED172E9728DA22540EF23F30FEDED?alternativeLink=True'>Subscribe to the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/7B8FCC540811FB9A2540EF23F30FEDED/C67FD2F38AC4859C/?tx=0&previewAll=1&print=1&source=PrintPreview&context=BE1559E32AC7F640D744A813E2B67A32'>Visit ASAM</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Lead: Evaluation of a Novel Patient-Centered Methadone Restart Protocol

This Week in Addiction Medicine from ASAM

AI Chapters

AI Insights

Reviews